Predictors of the isolated hepatitis B core antibody pattern in HIV-infected and-uninfected men in the multicenter AIDS cohort study

Clinical Infectious Diseases

Volumn 56, Issue 4, 2013, Pages 606-612

  Witt, Mallory D ^a,b   Lewis, Roger J ^a,b   Rieg, Gunter ^a,b   Seaberg, Eric C ^c   Rinaldo, Charles R ^e   Thio, Chloe L ^d  

^a HARBOR UCLA MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

hepatitis B core antibody; hepatitis C; highly active antiretroviral therapy; human immunodeficiency virus

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIRETROVIRUS AGENT; ASPARTATE AMINOTRANSFERASE; HEPATITIS B CORE ANTIBODY;

ARTICLE; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; DISEASE ASSOCIATION; FOLLOW UP; HEPATITIS C; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; VIRAL CLEARANCE;

ADULT; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; COINFECTION; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B CORE ANTIGENS; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; SEROLOGIC TESTS;

EID: 84873030109     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cis908     Document Type: Article

References (27)

1. Lok AS, McMahon BJ. Chronic hepatitis B. Hepatology 2007; 45:507-39.
2. Mofenson LM, Brady MT, Danner SP, et al. Guidelines for the prevention and treatment of opportunistic infections among HIV-exposed and HIV-infected children: recommendations from CDC, the national institutes of health, the HIV medicine association of the infectious diseases society of America, the pediatric infectious diseases society, and the American academy of pediatrics. MMWR Recomm Rep 2009; 58(RR-11):1-166.
3. French AL, Operskalski E, Peters M, et al. Isolated hepatitis B core antibody is associated with HIV and ongoing but not resolved hepatitis C virus infection in a cohort of US women. J Infect Dis 2007; 195:1437-42.
4. French AL, Lin MY, Evans CT, et al. Long-term serologic follow-up of isolated hepatitis B core antibody in HIV-infected and HIV-uninfected women. Clin Infect Dis 2009; 49:148-54.
5. Neau D, Winnock M, Galperine T, et al. Isolated antibodies against the core antigen of hepatitis B virus in HIV-infected patients. HIV Med 2004; 5:171-3.
6. Wedemeyer H, Cornberg M, Tegtmeyer B, Frank H, Tillmann HL, Manns MP. Isolated anti-HBV core phenotype in anti-HCV-positive patients is associated with hepatitis C virus replication. Clin Microbiol Infect 2004; 10:70-2.
7. Gandhi RT, Wurcel A, Lee H, et al. Isolated antibody to hepatitis B core antigen in human immunodeficiency virus type-1-infected individuals. Clin Infect Dis 2003; 36:1602-5.
8. Greub G, Frei PC. Isolated antibody to hepatitis B core is associated with hepatitis C virus co-infection. Clin Microbiol Infect 2000; 6:629.
9. Perez-Rodriguez MT, Sopena B, Crespo M, et al. Clinical significance of "anti-HBc alone" in human immunodeficiency virus-positive patients. World J Gastroentero 2009; 15:1237-41.
10. Jongjirawisan Y, Ungulkraiwit P, Sungkanuparph S. Isolated antibody to hepatitis B core antigen in HIV-1 infected patients and a pilot study of vaccination to determine the anamnestic response. J Med Assoc Thailand 2006; 89:2028-34.
11. Gandhi RT, Wurcel A, Lee H, et al. Response to hepatitis B vaccine in HIV-1-positive subjects who test positive for isolated antibody to hepatitis B core antigen: implications for hepatitis B vaccine strategies. J Infect Dis 2005; 191:1435-41.
12. Piroth L, Binquet C, Vergne M, et al. The evolution of hepatitis B virus serological patterns and the clinical relevance of isolated antibodies to hepatitis B core antigen in HIV infected patients. J Hepatol 2002; 36:681-6.
13. Sun HY, Lee HC, Liu CE, et al. Factors associated with isolated antihepatitis B core antibody in HIV-positive patients: impact of compromised immunity. J Viral Hepatitis 2010; 17:578-87.
14. Cohen Stuart JW, Velema M, Schuurman R, Boucher CA, Hoepelman AI. Occult hepatitis B in persons infected with HIV is associated with low CD4 counts and resolves during antiretroviral therapy. J Med Virol 2009; 81:441-5.
15. Pondé RAA, Cardoso DDP, Ferro MD. The underlying mechanisms for the 'anti-HBc alone' serological profile. Arch Virol 2010; 155: 149-58.
16. Chakvetadze C, Bani-Sadr F, Le Pendeven C, et al. Serologic response to hepatitis B vaccination in HIV-Infected patients with isolated positivity for antibodies to hepatitis B core antigen. Clin Infect Dis 2010; 50:1184-6.
17. Tseng KC, Lei HY, Cheng PN, et al. Immune response to hepatitis B vaccine of subjects with isolated antibody to hepatitis B core antigen. Hepato-gastroenterol 2003; 50:1474-7.
18. Ural O, Findik D. The response of isolated anti-HBc positive subjects to recombinant hepatitis B vaccine. J Infect 2001; 43:187-90.
19. McIntyre A, Nimmo GR, Wood GM, Tinniswood RD, Kerlin P. Isolated hepatitis B core antibody-can response to hepatitis B vaccine help elucidate the cause? Aust NZ J Med 1992; 22:19-22.
20. Liang SH, Chen TJ, Lee SS, et al. Risk factors of isolated antibody against core antigen of hepatitis B virus: association with HIV infection and age but not hepatitis C virus infection. J Acq Immun Def Synd 2010; 54:122-8.
21. Sheng WH, Kao JH, Chen PJ, et al. Evolution of hepatitis B serological markers in HIV-infected patients receiving highly active antiretroviral therapy. Clin Infect Dis 2007; 45:1221-9.
22. Quaglio G, Lugoboni F, Vento S, et al. Isolated presence of antibody to hepatitis B core antigen in injection drug users: do they need to be vaccinated? Clin Infect Dis 2001; 32:E143-4.
23. Kaslow RA, Ostrow DG, Detels R, Phair JP, Polk BF, Rinaldo CR Jr. The multicenter AIDS cohort study: rationale, organization, and selected characteristics of the participants. Am J Epidemiol 1987; 126:310-8.
24. Dudley J, Jin S, Hoover D, Metz S, Thackeray R, Chmiel J. The multicenter AIDS cohort study: retention after 9 1/2 years. Am J Epidemiol 1995; 142:323-30.
25. Zeger SL, Liang KY, Albert PS. Models for longitudinal data: a generalized estimating equation approach. Biometrics 1988; 44:1049-60.
26. Chu CJ, Lee SD. Hepatitis B virus/hepatitis C virus coinfection: epidemiology, clinical features, viral interactions and treatment. J Gastroen Hepatol 2008; 23:512-20.
27. Biggar RJ, Goedert JJ, Hoofnagle J. Accelerated loss of antibody to hepatitis B surface antigen among immunodeficient homosexual men infected with HIV. New Engl J Med 1987; 316:630-1.